These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 9531195)
1. Dual 1,25-dihydroxyvitamin D3 signal response pathways in osteoblasts: cross-talk between genomic and membrane-initiated pathways. Farach-Carson MC; Ridall AL Am J Kidney Dis; 1998 Apr; 31(4):729-42. PubMed ID: 9531195 [TBL] [Abstract][Full Text] [Related]
2. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. Kim S; Shevde NK; Pike JW J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825 [TBL] [Abstract][Full Text] [Related]
3. 22-Oxacalcitriol: dissection of 1,25(OH)2D3 receptor-mediated and Ca2+ entry-stimulating pathways. Farach-Carson MC; Abe J; Nishii Y; Khoury R; Wright GC; Norman AW Am J Physiol; 1993 Nov; 265(5 Pt 2):F705-11. PubMed ID: 8238551 [TBL] [Abstract][Full Text] [Related]
4. Target gene activation by 1,25-dihydroxyvitamin D3 in osteosarcoma cells is independent of calcium influx. Khoury R; Ridall AL; Norman AW; Farach-Carson MC Endocrinology; 1994 Dec; 135(6):2446-53. PubMed ID: 7988430 [TBL] [Abstract][Full Text] [Related]
5. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice. Chow EC; Quach HP; Vieth R; Pang KS Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451 [TBL] [Abstract][Full Text] [Related]
6. Evidence for coordinated regulation of osteoblast function by 1,25-dihydroxyvitamin D3 and parathyroid hormone. van Leeuwen JP; Birkenhäger JC; van den Bemd GC; Pols HA Biochim Biophys Acta; 1996 Jun; 1312(1):54-62. PubMed ID: 8679716 [TBL] [Abstract][Full Text] [Related]
7. Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3. Norman AW; Bouillon R; Farach-Carson MC; Bishop JE; Zhou LX; Nemere I; Zhao J; Muralidharan KR; Okamura WH J Biol Chem; 1993 Sep; 268(27):20022-30. PubMed ID: 8397195 [TBL] [Abstract][Full Text] [Related]
8. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138 [TBL] [Abstract][Full Text] [Related]
9. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation. Raval-Pandya M; Freedman LP; Li H; Christakos S Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705 [TBL] [Abstract][Full Text] [Related]
10. Nongenomic actions of 1,25-dihydroxyvitamin D3 in rat osteosarcoma cells: structure-function studies using ligand analogs. Farach-Carson MC; Sergeev I; Norman AW Endocrinology; 1991 Oct; 129(4):1876-84. PubMed ID: 1655387 [TBL] [Abstract][Full Text] [Related]
11. Vitamin D metabolites modulate osteoblast activity by Ca+2 influx-independent genomic and Ca+2 influx-dependent nongenomic pathways. Khoury RS; Weber J; Farach-Carson MC J Nutr; 1995 Jun; 125(6 Suppl):1699S-1703S. PubMed ID: 7782930 [TBL] [Abstract][Full Text] [Related]
12. Bioactive analogs that simulate subsets of biological activities of 1alpha,25(OH)(2)D(3) in osteoblasts. Farach-Carson MC Steroids; 2001; 66(3-5):357-61. PubMed ID: 11179744 [TBL] [Abstract][Full Text] [Related]
13. Interrelationship between signal transduction pathways and 1,25(OH)2D3 in UMR106 osteoblastic cells. Yang W; Hyllner SJ; Christakos S Am J Physiol Endocrinol Metab; 2001 Jul; 281(1):E162-70. PubMed ID: 11404234 [TBL] [Abstract][Full Text] [Related]
14. Structure-function studies of 1,25-dihydroxyvitamin D3 and the vitamin D endocrine system. 1,25-dihydroxy-pentadeuterio-previtamin D3 (as a 6-s-cis analog) stimulates nongenomic but not genomic biological responses. Norman AW; Okamura WH; Farach-Carson MC; Allewaert K; Branisteanu D; Nemere I; Muralidharan KR; Bouillon R J Biol Chem; 1993 Jul; 268(19):13811-9. PubMed ID: 8390978 [TBL] [Abstract][Full Text] [Related]
15. Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3. Christakos S; Raval-Pandya M; Wernyj RP; Yang W Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):361-71. PubMed ID: 8687373 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element. Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478 [TBL] [Abstract][Full Text] [Related]
17. Integrating rapid responses to 1,25-dihydroxyvitamin D3 with transcriptional changes in osteoblasts: Ca2+ regulated pathways to the nucleus. Farach-Carson MC; Bergh JJ; Xu Y Steroids; 2004 Aug; 69(8-9):543-7. PubMed ID: 15288767 [TBL] [Abstract][Full Text] [Related]
18. 1,25-Dihydroxyvitamin D3 analog structure-function assessment of the rapid stimulation of intestinal calcium absorption (transcaltachia). Zhou LX; Nemere I; Norman AW J Bone Miner Res; 1992 Apr; 7(4):457-63. PubMed ID: 1319106 [TBL] [Abstract][Full Text] [Related]
19. Nongenomic actions of the steroid hormone 1 alpha,25-dihydroxyvitamin D3. Baran DT J Cell Biochem; 1994 Nov; 56(3):303-6. PubMed ID: 7876322 [TBL] [Abstract][Full Text] [Related]
20. The rapid nongenomic actions of 1 alpha,25-dihydroxyvitamin D3 modulate the hormone-induced increments in osteocalcin gene transcription in osteoblast-like cells. Baran DT; Sorensen AM; Shalhoub V; Owen T; Stein G; Lian J J Cell Biochem; 1992 Oct; 50(2):124-9. PubMed ID: 1429879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]